Technologies

​ LJUBLJANA, Slovenia, June 27, 2024 /PRNewswire/ — Slovenian gastronomy has achieved another milestone. In 2024 Michelin Guide for Slovenia, the number of listed restaurants has risen to 63, an increase of four from the… Read More »Slovenia Celebrates 10 Michelin-Starred Restaurants: Hiša Franko Maintains Three Stars. Restaurant Milka Retains Two, and Pavus Earns a New Star

Los Angeles, USA, June 26, 2024 (GLOBE NEWSWIRE) — In a groundbreaking initiative aimed at educating cryptocurrency investors, William Miller, CEO of OkayCoin, today shared invaluable insights into common crypto staking mistakes and strategies for avoiding… Read More »OkayCoin CEO Shares Expert Advice on How to Navigate Crypto Staking Successfully

London, England, June 26, 2024 (GLOBE NEWSWIRE) — ValueZone, a leading platform in cryptocurrency trading, emphasises the critical importance of understanding trading volume as a fundamental metric in the cryptocurrency market. In its comprehensive 2024 review,… Read More »ValueZone Highlights the Critical Role of Trading Volume in Crypto Market Analysi

​ Crazy Domains leverages AI to simplify building websites for SMBs SYDNEY, June 27, 2024 /PRNewswire/ — Crazy Domains, one of Australia and New Zealand’s top domain and hosting providers delivers its new AI Website Builder to… Read More »Crazy Domains Delivers New AI Website Builder

Arturo Rodriguez Appointed CEO Josh Feldman Appointed CFO Second Quarter 2024 Net Revenue Range Improved to Between $23 Million to $26 Million Second Quarter 2024 Adjusted EBITDA Range Improved to Between a Loss of ($1.0)… Read More »Aterian Announces Leadership Changes & Improved Second Quarter 2024 Net Revenue and Adjusted EBITDA Ranges

New investment and debt conversion by new and existing investors sets company’s post-money valuation at approximately $220 million, up 214% from previous funding round.Financing supports further expansion of NeOnc’s NEO platform technology that has produced… Read More »NeOnc Technologies Completes $18.5 Million Financing, Advances Phase II Clinical Trials for Enhanced Method of Delivering Novel Therapeutics to the Brain Under FDA Fast-Track Status